Showing results (61-70 of 71) with videos related to
Sort By:
Pageof 8
Cancer & Metabolism|November 20, 2024
Glutaminolysis is associated with mitochondrial pathway activation and can be therapeutically targeted in glioblastomaKenji Miki, Mikako Yagi, Ryusuke Hatae, et al.Brain & Development|September 25, 2025
Glutamate in cerebrospinal fluid as a diagnostic marker for acute encephalopathy in childhoodKenta Kajiwara, Daiki Setoyama, Kanako Higashi, et al.Neuroscience Research|March 5, 2023
Shank3a/b isoforms regulate the susceptibility to seizures and thalamocortical development in the early postnatal period of miceSayaka Okuzono, Fumihiko Fujii, Yuki Matsushita, et al.Plos One|December 17, 2016
Plasma Metabolites Predict Severity of Depression and Suicidal Ideation in Psychiatric Patients-A Multicenter Pilot AnalysisDaiki Setoyama, Takahiro A Kato, Ryota Hashimoto, et al.Scientific Reports|May 20, 2022
Cancer genomic profiling identified dihydropyrimidine dehydrogenase deficiency in bladder cancer promotes sensitivity to gemcitabineShigehiro Tsukahara, Masaki Shiota, Dai Takamatsu, et al.Genes to Cells : Devoted to Molecular & Cellular Mechanisms|July 4, 2024
An N-terminal and ankyrin repeat domain interactome of Shank3 identifies the protein complex with the splicing regulator Nono in miceSayaka Okuzono, Fumihiko Fujii, Daiki Setoyama, et al.Journal of Cachexia, Sarcopenia and Muscle|April 10, 2025
Comparative Analysis of Primary Sarcopenia and End-Stage Renal Disease-Related Muscle Wasting Using Multi-Omics ApproachesDaiki Setoyama, Dohyun Han, Jingwen Tian, et al.Scientific Reports|October 26, 2017
Dysregulated gene expressions of MEX3D, FOS and BCL2 in human induced-neuronal (iN) cells from NF1 patients: a pilot studyNoriaki Sagata, Takahiro A Kato, Shin-Ichi Kano, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 27, 2020
GNAO1 organizes the cytoskeletal remodeling and firing of developing neuronsSatoshi Akamine, Sayaka Okuzono, Hiroyuki Yamamoto, et al.Cell Reports|May 4, 2017
Targeting Ras-Driven Cancer Cell Survival and Invasion through Selective Inhibition of DOCK1Hirotada Tajiri, Takehito Uruno, Takahiro Shirai, et al.Pageof 8